Evaluating the effectiveness of a social robot intervention on pain management in people with dementia living in residential aged care facilities: A cluster randomised controlled trial

Not Applicable

Recruiting

• Conditions: Dementia; Chronic pain; Neurological - Dementias; Anaesthesiology - Pain management

• Registration Number: ACTRN12621001010886
• Lead Sponsor: Griffith University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-08-02
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 92

Inclusion Criteria

(1) Age 65 years and older and can speak and understand English.
(2) Participants must have been diagnosed with some form of dementia.
(3) Participants are assumed to experience chronic pain if they report and have regular pain medication.
(4) Demonstration of sensation and perception to allow interaction with PARO.
(5) Living in the care facility for more than 3 months.

Exclusion Criteria

(1) Diseases such as acute exacerbation of chronic obstructive pulmonary disease that requires residents to be admitted to hospital frequently;
(2) Terminal illnesses where the resident is in the final palliative stage;
(3) A diagnosis of a major mental illness, such as schizophrenia;
(4) A diagnosis of Parkinson’s Disease as their facial features could have been compromised due to the nature and progress of the condition; and
(5) Infectious diseases, such as acquired immune deficiency syndrome, COVID-19, or tuberculosis, or an open wound that is unable to be covered.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain levels measured by PainChek app [Assessed before and after each PARO or Plush-toy session (primary endpoint) for 4 weeks];Pain levels measured by the Abbey Pain Scale[Assessed at baseline, weeks 4 (primary endpoint) and week 8 after commencement of the intervention.];Neuropsychiatric symptoms using the Neuropsychiatric Inventory-nursing home version[Assessed at baseline, weeks 4 (primary endpoint) and week 8 after commencement of the intervention.]